Malaysia's biotech sector exceeds investment target of RM9bil


PUCHONG: The local biotechnology industry, facilitated by Malaysian Biotechnology Corp Sdn Bhd (BiotechCorp), has accrued a total investment of RM12bil since 2011, surpassing the Government’s five-year target under the National Biotechnology Policy (NBP).

The policy, currently in its second phase, had originally aimed to achieve RM9bil in investments by the end of 2015. The first five-year phase attracted RM5.4bil.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , BiotechCorp , BioNexus , BioShoppe , Nova , MOSTI

   

Next In Business News

Rafizi: Economy continues to strengthen along with Bursa Malaysia
MAHB's 1Q24 traffic hits more than 90% recovery rate against 1Q19
IRDA's RM636bil investment goal to help propel Malaysia into top 30 global economies
DXN Holdings net profit for FY24 rises to RM310.99mil
Ringgit closes slightly lower against US dollar
Inta Bina bags RM170mil construction job
PETRONAS Gas commits to sustainability, announces total dividend of 72 sen per share
Crest Builder bags RM486mil condo job
Axis-REIT optimistic of maintaining its current performance for FY24
KIP REIT aims for RM2bil AUM

Others Also Read